Navigation Links
BioCryst Provides Forodesine HCl Update
Date:12/6/2007

BIRMINGHAM, Ala., Dec. 6 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today provided an update to the Company's forodesine HCl development program

Forodesine HCl Data to be Presented at American Society of Hematology Meeting

Madeleine Duvic, M.D., Deputy Chair, Dermatology, The University of Texas M.D. Anderson Cancer Center, is scheduled to present interim data from the Phase I/II clinical study of oral forodesine HCl in the treatment of patients with refractory cutaneous T-cell lymphoma (CTCL) at the annual meeting of the American Society of Hematology (ASH) in Atlanta, Georgia at 4:45 pm on Sunday, December 9.

Dr. Duvic's presentation entitled, "Response to Oral Forodesine in Refractory Cutaneous T-Cell Lymphoma: Interim Results of a Phase I/II Study" will provide additional data and analyses from this ongoing trial to supplement information presented at the 2006 ASH meeting.

BioCryst to Voluntarily Discontinue Clinical Study of Intravenous Forodesine HCl in Patients with T-ALL

After review and consultation with Mundipharma, BioCryst has decided to voluntarily and formally discontinue its Phase IIb clinical trial of intravenous (i.v.) forodesine HCl in the treatment of patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL). This was the only current trial using the i.v. formulation. The other clinical trials of forodesine HCl, including the CTCL trials, which are utilizing the oral capsule formulation, are not affected by this action and those trials continue. The decision to discontinue the trial in T-ALL is related to the delays associated with addressing the previously announced stability issue, the limited number of patients with T-AL
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
2. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
3. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
4. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
5. Raptor Pharmaceuticals Provides Update of Product Programs
6. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
7. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
8. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
11. Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , Switzerland and ... 2013 Cenix BioScience, a ... specialized in RNAi-, miRNA- and high content-driven pharmacology, ... group of companies with a focus on the ... needs, including oncology and companion diagnostics, today announced ...
(Date:5/22/2013)... Colo. , May 22, 2013  Heska Corporation (NASDAQ: ... diagnostic and specialty products, announced today that the Company will ... Wednesday, May 29, 2013 at the Le Parker Meridian hotel, ... York City . The presentation is scheduled to begin ... About Heska Heska Corporation (NASDAQ: ...
(Date:5/22/2013)... , May 22, 2013 /PRNewswire-iReach/ -- World markets ... with the latest trends and events, companies now ... predict where an industry is headed next, so ... (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... market research publisher GlobalData, offer decision makers and ...
Breaking Medicine Technology:Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4
... Nov. 29, 2011 Uptake Medical® today announced the ... lung volume reduction in a patient with severe emphysema. ... endoscopic lung volume reduction system for the treatment of ... without leaving foreign materials in the lung. The patient ...
... IRVING, Texas, Nov. 29, 2011 A new study in ... has uncovered a novel mechanism that cancer cells may use ... "Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T ... Moffitt Cancer Center in Tampa, Fla., shows that a specific ...
Cached Medicine Technology:Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema 2Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema 3New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 3
(Date:5/23/2013)... 23, 2013 Canadian Healthy Vending ... Healthy Vending Machines, and that's in sync with the ... for the Canada Organic Trade Association (COTA). The report ... and beverages each year. This makes the burgeoning organic ... , As a Canadian leader in healthy vending ...
(Date:5/23/2013)... Great defined abs are the embodiment of being in ... in the gym yet so many fall short of this ... become a reality. Great abdominal muscles are acquired in the ... Tischler of Tischler Brothers Fitness explains four of these easy ... great abs. , 1.    Go to bed early. The body does ...
(Date:5/23/2013)... 23, 2013 Pittsburgh-based company Automated ... remain independent in their own homes for as long ... of Life Safety, recently commented on how the company ... stated that although there are numerous companies in the ... is rare in that they are dedicated only to ...
(Date:5/23/2013)... Group Home Buy made its debut at a ... tour of the latest properties coming up in town. The ... thus availing a concession on the prices of the flats. ... home buyers for the services rendered to them. , ... Group Home Buy will be the commission that it charges ...
(Date:5/23/2013)... Fredericton, NB (PRWEB) May 23, 2013 ... contact center software for Asterisk telephony, ... a self-regulating Automatic Monitoring and Decision Making System ... High Availability and offer call survival. The new ... self-regulating overseer mechanism, thereby enhancing reliability. , Large ...
Breaking Medicine News(10 mins):Health News:Max! Healthy Vending Machines in Tune with Burgeoning Organic Foods Market 2Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:Automated Security Alert's New Medical Alarm Works Even In Power Outages 2Health News:Group Home Buy, a Unique Facility for Home Buyers, Launched in Style 2Health News:Indosoft Upgrades its Overseer Watchdog System for Q-Suite to Enhance High Availability with Call Survival for Mission Critical ACD Applications 2
... Aggressively managing patients at risk for osteoporosis could reduce ... percent, according to a Kaiser Permanente study published in the ... Surgery . The first step must be a more active ... This study, the largest to look at osteoporosis management ...
... find , MONDAY, Nov. 2 (HealthDay News) -- ... achieve lower levels of education, employment and income than ... a U.S. study has found. , The findings, published ... of Neuropsychology , highlight the importance of programs ...
... sipping cocoa, snuggling under blankets and heart attacks all have ... winter months. , According to the Centers for Disease ... a heart attack or similar cardiac event during or after ... help create awareness, work to lower that number, and highlight ...
... Nov. 2 Sunrise Senior Living, Inc. (NYSE: SRZ ... and Webcast on Monday, November 9, 2009, at 9:00 a.m. ... Mark Ordan, chief executive officer, and Julie Pangelinan, chief financial ... for the conference call is 888-516-2435 or 719-325-2260 (from outside ...
... ... the U.S. Martel provides custom printer solutions for products such as manufacturing equipment, medical ... the U.S. include Abbott Laboratories. , ... (PRWEB) November 2, 2009 -- Martel Instruments Ltd. , a ...
... , National Sleep Foundation Launches Annual Drowsy Driving Prevention ... , WASHINGTON, Nov. 2 Sleepiness is often overlooked as a ... Sleep in America poll shows that 1% or as many ... near miss due to drowsiness in the past year. Even more ...
Cached Medicine News:Health News:Nation's hip fracture rate could drop 25 percent with aggressive osteoporosis prevention 2Health News:Nation's hip fracture rate could drop 25 percent with aggressive osteoporosis prevention 3Health News:Childhood Brain Cancer Causes Other Long-Term Problems 2Health News:MTD Joins Forces with the AHA to Promote Heart Health 2Health News:Sunrise to Host Conference Call and Webcast to Discuss Third-Quarter 2009 Financial Results 2Health News:Martel Instruments Expands Its Custom Printer Solutions Business in North America; Liz Peirce Named Director of North American Business Development 2Health News:1.9 Million Drivers Have Fatigue-Related Car Crashes or Near Misses Each Year 2Health News:1.9 Million Drivers Have Fatigue-Related Car Crashes or Near Misses Each Year 3Health News:1.9 Million Drivers Have Fatigue-Related Car Crashes or Near Misses Each Year 4
... knee system is a long ... a clinically proven design. Available ... anatomically correct cruciate retaining configurations. ... ease of identification keeps the ...
The Foundation PS knee offers a femoral option and tibial insert which provides a specially designed cam action that engages at 60 degrees of flexion to induce a smooth stable femoral roll-back motio...
... for patients with difficult problems in total ... to repair difficult anatomic conditions. It has ... the chance of dislocation in extension through ... and updated so that the components can ...
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i...
Medicine Products: